Jaguar Health (JAGX) EBT Growth (3y) (2017 - 2026)
Jaguar Health (JAGX) EBT Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
28.95% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-49.71% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
20.92% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
12.01% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
39.31% |
| Date | Value |
|---|
| Mar 31, 2026 |
39.31% |
| Dec 31, 2025 |
-41.24% |
| Sep 30, 2025 |
8.54% |
| Jun 30, 2025 |
-3.99% |
| Mar 31, 2025 |
16.44% |
| Dec 31, 2024 |
10.59% |
| Sep 30, 2024 |
6.33% |
| Jun 30, 2024 |
11.90% |
| Mar 31, 2024 |
7.95% |
| Dec 31, 2023 |
-2.01% |
| Sep 30, 2023 |
-0.16% |
| Jun 30, 2023 |
-9.99% |
| Mar 31, 2023 |
-16.03% |
| Dec 31, 2022 |
-11.37% |
| Sep 30, 2022 |
-18.67% |
| Jun 30, 2022 |
13.04% |
| Mar 31, 2022 |
-29.81% |
| Dec 31, 2021 |
-4.20% |
| Sep 30, 2021 |
-25.70% |
| Jun 30, 2021 |
-21.81% |
